Long-Term Survival Outcomes of Modified-FOLFOXIRI Plus Cetuximab Versus Bevacizumab in RAS / BRAF Wild-Type Metastatic Colorectal Cancer: Final Analysis of the DEEPER Trial - Yu Sunakawa; Manabu Shiozawa; Takanori Watanabe; Hirofumi Ota; Hisateru Yasui; Taichi Yabuno; Mitsuyoshi Tei; Mitsugu Kochi; Dai Manaka; Hisatsugu Ohori; Tatsuro Yamaguchi; Tamotsu Sagawa; et al. (Journal of Clinical Oncology, 2026)